by Diana Zapata •
News Writer /Editorial Specialist
Published November 10, 2026
The United States is facing the possibility of losing its measles elimination status as the country experiences a significant resurgence of infections, prompting renewed concerns among public health authorities about vaccination coverage, disease surveillance, and the prevention of further outbreaks.
According to the U.S. Centers for Disease Control and Prevention (CDC), 5,182 confirmed measles cases had been reported nationwide as of November 5, 2026, involving 47 jurisdictions. The figure represents a substantial increase from the 2,289 confirmed cases recorded throughout 2025.
The CDC also reported 43 measles outbreaks in 2026, with approximately 96% of confirmed infections associated with outbreaks. The figures highlight the continuing spread of a highly contagious disease that had previously been eliminated through sustained vaccination efforts.
International review could determine the country’s status
The Pan American Health Organization (PAHO) is conducting a review of the United States’ measles elimination status during its November 10–13, 2026, meeting.
An independent regional commission of public health and epidemiology experts will examine whether measles transmission has continued uninterrupted for at least 12 months.
The assessment will include epidemiological evidence and genetic sequencing of measles viruses to determine whether outbreaks in different parts of the country are connected to the transmission chain that began in West Texas in January 2025.
Under international elimination criteria, a country can lose its measles-free designation if the same virus genotype and lineage circulate continuously within its territory for at least 12 months.
The commission’s findings will be submitted to the PAHO director, who will formally communicate the resulting classification to national authorities. As of November 11, the review is underway, and a final determination has not yet been announced.
Vaccination Coverage remains a Major Public Health concern
Health experts have identified vaccination coverage as an important factor in preventing further measles transmission.
The measles, mumps, and rubella (MMR) vaccine provides approximately 97% protection against measles after two doses. Public health authorities generally recommend that at least 95% of a population be vaccinated to maintain sufficient community protection and reduce the likelihood of widespread outbreaks.
However, vaccination coverage has declined in some parts of the United States, leaving certain communities more vulnerable to infection.
Measles spreads through the air when an infected person breathes, coughs, or sneezes. The virus can cause fever, cough, runny nose, red eyes, and a characteristic skin rash. In severe cases, complications can include pneumonia, brain inflammation, hospitalization, and death.
Infants, young children, and individuals with weakened immune systems are particularly vulnerable to serious complications.
Public Health Implications
The potential loss of measles elimination status would represent a significant development in the country’s public health history. The United States achieved measles elimination in 2000 after years of vaccination programs and disease-control efforts.
However, elimination does not mean that measles has disappeared worldwide or that imported infections cannot occur. Instead, it means that continuous domestic transmission has been interrupted for at least 12 months.
The current situation highlights the importance of maintaining vaccination programs, strengthening disease surveillance, improving public access to immunization services, and responding promptly to new outbreaks.
Although the designation itself does not determine the severity of individual infections, its possible loss would indicate that sustained transmission has undermined a major public health achievement.
As international health authorities review the available evidence, the outcome will provide an important assessment of the country’s ability to prevent and control the spread of vaccine-preventable diseases.
